Staturo-Weight Growth at 12 Months in Macrosomic Newborns at the Mother and Child University Hospital Center Foundation Jeanne Ebori from 2022 to 2023

Introduction: Fetal macrosomia is a public health problem because of the significant morbidity and mortality it causes, particularly in sub-Saharan Africa. Objective: To evaluate the staturo-weight growth of macrosomic newborns in the short and medium term at the Foundation Jeanne Ebori mother-child university hospital (CHUME-FJE) in Libreville from 2022 to 2023. Patients and methods: This was a prospective, longitudinal, analytical cohort study conducted over a period of 18 months. Patients were included if they had a birth weight (BW) greater than the 90th percentile of the reference curves, regardless of term. Statistical analysis was performed using R software version 3.4. The significance threshold was defined as p Results: 100/1389 deliveries had a birth weight above the 90th percentile (frequency of 7.2%). The mean GA was 39.1 ± 1.8 SA with a sex ratio of 2.3 and a mean birth weight of 4081.5 g ± 391.2 g. From birth to 12 months, growth in stature, weight, staturo-weight and head circumference was normal. At 12 months, height was normal (100%), 35.0% of infants remained obese and 51.7% had macrocrania. Conclusion: Macrosomia is a public health problem. Much remains to be done to reduce the frequency of macrosomia and improve survival, particularly by raising awareness of the risks associated with obesity, diabetes and conception at an advanced age, and of the advantages of family planning, improving pregnancy monitoring and the quality of care.